Threshold Pharmaceuticals Announces Initiation Of Phase 3 Trial In Europe For The Treatment Of Benign Prostatic Hyperplasia
Tuesday, 09 August 2005
Threshold Pharmaceuticals Inc. today announced the initiation of a Phase 3 clinical trial as part of a registrational program of its investigational drug candidate TH-070 (lonidamine).
read more
|
BJUI Mini Reviews - Selecting Therapy for Maintaining Sexual Function in Patients with Benign Prostatic Hyperplasia
Monday, 01 August 2005
As QoL becomes
more of a consideration in managing BPH, the
effects of BPH treatment on sexual function
need to be included in patient management
decisions.
Login to read more...
|
BJUI Mini Reviews - Targeting Bladder Outlet Obstruction from Benign Prostatic Enlargement Via the Nitric Oxide/cGMP Pathway?
Monday, 01 August 2005
This review
considers the available knowledge about the
significance of the NO/cGMP pathway for
treating BOO and concomitant LUTS related to
BPE.
Login to read more...
|
BJUI Mini Reviews - The Vital Role of Creativity in Academic Departments
Monday, 01 August 2005
A university department with creativity
potentially improves its capacity to compete
for funding, people, reputation and,
eventually, postgraduate students.
Login to read more...
|
Authors Examine The Association Of Cigarette Smoking, Alcohol Consumption and Physical Activity With Lower Urinary Tract Symptoms
Tuesday, 19 July 2005
BERKELEY, CA (UroToday Inc.) - Lower urinary tract symptoms (LUTS) are a common and bothersome condition in older men. Despite the high prevalence of LUTS, not much is known about their causes as not all men with symptoms have an enlarged prostate.
read more
|
UK?S National Institute For Health and Clinical Excellence Approves PVP Procedure At National Health Service Hospitals
Tuesday, 19 July 2005
SAN JOSE, Calif. (July 19, 2005) -- Laserscope (Nasdaq: LSCP), a pioneer in the
development and commercialization of medical lasers and advanced fiber-optic delivery
devices, announced today that the United Kingdom?s National Institute for Health and Clinical
Excellence (NICE) has approved the Photoselective Vaporization of the Prostate (PVP)
procedure for the treatment of Benign Prostatic Hyperplasia, or BPH, at National Health Service
(NHS) hospitals in England and Wales.
read more
|
NSAID Use Linked To Acute Urinary Retention
Tuesday, 12 July 2005
NEW YORK (Reuters Health) - Regular use of NSAIDs may double the risk of acute urinary retention in men, new research suggests.
read more
|
Symptom Complexes Diverse Among Men Diagnosed with Benign Prostatic Hyperplasia
Friday, 08 July 2005
BERKELEY, CA (UroToday Inc.) - "Lower urinary tract symptoms" (LUTS) has become the preferred term used to classify the urinary symptoms of elderly men.
read more
|
Symptom Complexes Diverse Among Men Diagnosed with Benign Prostatic Hyperplasia
Tuesday, 05 July 2005
BERKELEY, CA (UroToday Inc.) - "Lower urinary tract symptoms" (LUTS) has become the preferred term used to classify the urinary symptoms of elderly men.
read more
|
Ardana Reports Successful Phase II Results with Novel BPH Therapy
Friday, 27 May 2005
LONDON (Agence de Presse Medicale for Reuters Health) - The Scotttish reproductive health company Ardana said on Thursday its long-acting gonadotrophin-releasing hormone antagonist, Teverelix, had successfully completed a phase II study in patients with benign prostatic hyperplasia.
read more
|
BPH & Male LUTS 
